missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human LGI2 Synthetic Peptide
Click to view available options
Quantity:
50 μg
Unit Size:
50µg
Description
LGI2 Synthetic Peptide, PEP-0613, from Invitrogen.
The leucine-rich, glioma inactivated gene 2 (LGI2) is a member of the LGI family in which LGI1 is the exemplar. The LGI family consists of four of highly related proteins containing leucine-rich repeats (LRRs) which are highly similar to other transmembrane signaling molecules and receptors. LGI1 has been identified as a candidate tumor suppressor gene for glioma and plays a role in autodominant lateral temporal epilepsy (ADTLE), an epileptic syndrome characterized by focal seizures with predominant auditory symptoms. Despite its high homology with LGI1 and similar pattern of expression, mutations in LGI2 have not been found to be associated with ADTLE.

Specifications
Specifications
Gene ID (Entrez) | 55203 |
Species | Human |
Purification Method | purified |
Accession Number | Q8N0V4 |
Common Name | Human LGI2 |
Concentration | 200 μg/mL |
Content And Storage | -20°C |
Description | Synthetic Peptide |
Format | Liquid |
Formulation | PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 |
Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Invitrogen™ Human LGI2 Synthetic Peptide >
Spot an opportunity for improvement?Share a Content Correction